FATE
Fate Therapeutics Inc.
$1.39
-$0.24(-14.90%)
62
Overall
60
Value
91
Tech
36
Quality
Market Cap
$110.98M
Volume
2.06M
52W Range
$0.66 - $3.50
Target Price
$4.45
Key Metrics Overview
| Market Cap | $110.98M | P/E Ratio | N/A |
| 52W High | $3.50 | 52W Low | $0.66 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 9.9% | 52W Position | 25.8% |
| Overall Score | 62 | Value Score | 60 |
| Quality Score | 36 | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-1.1 | EPS Next Est | $-1.02 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.39 | -14.9% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |